Recent Posts
- Ilya Pharma Engages Partner International as ILP-technology and ILP100 advances in clinical trials
- OBIO 2020 Niagara Investment Summit Featuring Early Technology Showcase
- Genome Atlantic – The Future of Personalized Health & Human Performance
- NEWS RELEASE – Researchers Present New Positive Interim Data on Appili Therapeutics’ ATI-1701 Biodefense Program at 2019 Chemical and Biological Defense Science & Technology Conference
- Appili Therapeutics Acquires Clinical Stage Antifungal Program From FUJIFILM Toyama Chemical